Sanjeeb Kumar Sahoo
Impact in
- Biomaterials top 0.02%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.05%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 58
- Nanoparticle-Based Drug Delivery 54
-
- Curcumin's Biomedical Applications 13
- Co-authors
- Vinod LabhasetwarSuphiya ParveenSarbari AcharyaChandana MohantyRanjita MisraFahima DilnawazJayanth PanyamSwayam Prabha
- Journals
- Drug Discovery Today (10 papers)Molecular Pharmaceutics (9 papers)International Journal of Pharmaceutics (6 papers)Biomaterials (6 papers)Nanomedicine (5 papers)
- Partner nations
- IndiaUnited StatesJapan
In The Last Decade
Sanjeeb Kumar Sahoo
114 papers receiving 14.8k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Biomaterials 7.3k
- Pharmaceutical Science 2.7k
- Molecular Medicine 1.6k
- Biomedical Engineering 5.1k
- Molecular Biology 5.0k
Countries citing papers authored by Sanjeeb Kumar Sahoo
This map shows the geographic impact of Sanjeeb Kumar Sahoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjeeb Kumar Sahoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjeeb Kumar Sahoo more than expected).
Fields of papers citing papers by Sanjeeb Kumar Sahoo
This network shows the impact of papers produced by Sanjeeb Kumar Sahoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjeeb Kumar Sahoo. The network helps show where Sanjeeb Kumar Sahoo may publish in the future.
Co-authors
The 25 scholars most cited alongside Sanjeeb Kumar Sahoo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 20 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 23 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 35 | |
| 9 | 2022 | 29 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 19 | |
| 12 | 2014 | 51 | |
| 13 | Nanomedicine - Basic and clinical applications in diagnostics and therapy | 2012 | 3 |
| 14 | 2012 | 88 | |
| 15 | 2012 | 81 | |
| 16 | 2012 | 2 | |
| 17 | 2011 | 6 | |
| 18 | 2010 | 20 | |
| 19 | 2009 | 178 | |
| 20 | Nanotech approaches to drug delivery and imaging Hit paper breakdown → | 2003 | 818 |
About Sanjeeb Kumar Sahoo
Sanjeeb Kumar Sahoo is a scholar working on Biomaterials, Molecular Medicine, Pharmaceutical Science, Toxicology and Oncology, having authored 117 papers that have together received 15.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (54 papers), RNA Interference and Gene Delivery (27 papers), Advanced Drug Delivery Systems (16 papers), Curcumin's Biomedical Applications (13 papers), Nanoplatforms for cancer theranostics (12 papers), Graphene and Nanomaterials Applications (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Cancer Cells and Metastasis (8 papers). The work is most often cited by research in Biomaterials (7.3k citations), Pharmaceutical Science (2.7k citations), Molecular Medicine (1.6k citations), Biomedical Engineering (5.1k citations) and Molecular Biology (5.0k citations). Sanjeeb Kumar Sahoo has collaborated with scholars based in India, United States and Japan. Frequent co-authors include Vinod Labhasetwar, Suphiya Parveen, Sarbari Acharya, Chandana Mohanty, Ranjita Misra, Fahima Dilnawaz, Jayanth Panyam, Swayam Prabha, Manasi Das and Abhalaxmi Singh. Their work appears in journals such as Drug Discovery Today, Molecular Pharmaceutics, International Journal of Pharmaceutics, Biomaterials and Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.